Dr. Peter W. Hunt, MD
Infectious Disease (Infectious Disease Physician)
995 Potrero Ave, Sfgh Building 80, Ward 84
San Francisco, CA 94110
At a glance
- Medical school
- Yale University School of Medicine (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
Licensed in California since 2000, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: Yale University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Infectious Disease Physician primary
CA license A70944 (first issued 2000; current) -
Internal Medicine Physician
CA license A70944 (first issued 2000; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Zuckerberg San Francisco General Hosp & Trauma Ctr San Francisco, CA
Medical groups
- University of California Sfgh Medical Group (587 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Biktarvy (bictegrav/emtricit/tenofov ala) | 46 |
| Pifeltro (doravirine) | 18 |
| Lorazepam Other prescribers in San Francisco, CA | 14 |
| Amlodipine Besylate-Benazepril (amlodipine besylate/benazepril) Other prescribers in San Francisco, CA | 13 |
| Bupropion Hcl Sr (bupropion hcl) Other prescribers in San Francisco, CA | 13 |
| Tivicay (dolutegravir sodium) | 13 |
| Fluconazole Other prescribers in San Francisco, CA | 13 |
| Rosuvastatin Calcium Other prescribers in San Francisco, CA | 13 |
| Gabapentin Other prescribers in San Francisco, CA | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 23 payments worth $21,856 in total to this clinician.
| Merck Sharp & Dohme LLC | $21,856 |
|---|
| Consulting Fee | $17,400 |
|---|---|
| Travel and Lodging | $3,661 |
| Food and Beverage | $795 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC Oct 13, 2025 | Consulting Fee | $10,440 |
| Merck Sharp & Dohme LLC May 14, 2025 | Consulting Fee | $6,960 |
| Merck Sharp & Dohme LLC May 1, 2025 | Travel and Lodging travel to Philadelphia, PA · in-kind Company’s descriptionProvided as part of a research engagement. | $873 |
| Merck Sharp & Dohme LLC May 2, 2025 | Travel and Lodging travel to Philadelphia, PA · in-kind Company’s descriptionProvided as part of a research engagement. | $631 |
| Merck Sharp & Dohme LLC Sep 28, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $622 |
| Merck Sharp & Dohme LLC Sep 28, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $275 |
| Merck Sharp & Dohme LLC May 1, 2025 | Travel and Lodging travel to Philadelphia, PA · in-kind Company’s descriptionProvided as part of a research engagement. | $269 |
| Merck Sharp & Dohme LLC Sep 29, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $260 |
| Merck Sharp & Dohme LLC Sep 28, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $260 |
| Merck Sharp & Dohme LLC Sep 28, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $171 |
All 12 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC Oct 13, 2025 | Consulting Fee | $10,440 |
| Merck Sharp & Dohme LLC Oct 13, 2025 | Travel and Lodging travel to Philadelphia, PA | $150 |
| Merck Sharp & Dohme LLC Sep 29, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $260 |
| Merck Sharp & Dohme LLC Sep 28, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $622 |
| Merck Sharp & Dohme LLC Sep 28, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $275 |
| Merck Sharp & Dohme LLC Sep 28, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $260 |
| Merck Sharp & Dohme LLC Sep 28, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $171 |
| Merck Sharp & Dohme LLC May 14, 2025 | Consulting Fee | $6,960 |
| Merck Sharp & Dohme LLC May 14, 2025 | Travel and Lodging travel to Philadelphia, PA | $150 |
| Merck Sharp & Dohme LLC May 2, 2025 | Travel and Lodging travel to Philadelphia, PA · in-kind Company’s descriptionProvided as part of a research engagement. | $631 |
| Merck Sharp & Dohme LLC May 1, 2025 | Travel and Lodging travel to Philadelphia, PA · in-kind Company’s descriptionProvided as part of a research engagement. | $873 |
| Merck Sharp & Dohme LLC May 1, 2025 | Travel and Lodging travel to Philadelphia, PA · in-kind Company’s descriptionProvided as part of a research engagement. | $269 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.